Biotrend Cevre Ve Stock Number Of Shares Shorted
| BIOEN Stock | TRY 17.10 0.24 1.42% |
Biotrend Cevre ve fundamentals help investors to digest information that contributes to Biotrend Cevre's financial success or failures. It also enables traders to predict the movement of Biotrend Stock. The fundamental analysis module provides a way to measure Biotrend Cevre's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotrend Cevre stock.
Biotrend |
Biotrend Cevre ve Company Number Of Shares Shorted Analysis
Biotrend Cevre's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Biotrend Cevre ve has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Utilities sector and about the same as Utilities—Renewable (which currently averages 0.0) industry. The number of shares shorted for all Turkey stocks is 100.0% higher than that of the company.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Biotrend Fundamentals
| Return On Equity | 0.0978 | |||
| Return On Asset | 0.0657 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.22 % | |||
| Shares Owned By Insiders | 67.23 % | |||
| Shares Owned By Institutions | 1.80 % | |||
| Price To Earning | 114.34 X | |||
| Revenue | 427.7 M | |||
| Gross Profit | 123.34 M | |||
| EBITDA | 84.88 M | |||
| Net Income | 3.79 M | |||
| Cash And Equivalents | 25.91 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 696.56 M | |||
| Debt To Equity | 2.09 % | |||
| Current Ratio | 0.77 X | |||
| Book Value Per Share | 0.98 X | |||
| Cash Flow From Operations | (326.18 M) | |||
| Earnings Per Share | 0.01 X | |||
| Target Price | 13.1 | |||
| Number Of Employees | 529 | |||
| Total Asset | 1.83 B | |||
| Net Asset | 1.83 B |
About Biotrend Cevre Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotrend Cevre ve's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotrend Cevre using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotrend Cevre ve based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Biotrend Stock
Biotrend Cevre financial ratios help investors to determine whether Biotrend Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotrend with respect to the benefits of owning Biotrend Cevre security.